Nifty
Sensex
:
:
15885.15
52950.63
122.10 (0.77%)
363.79 (0.69%)

Pharmaceuticals & Drugs - Global

Rating :
60/99

BSE: 524735 | NSE: HIKAL

549.65
02-Aug-2021
  • Open
  • High
  • Low
  • Previous Close
  •  535.00
  •  565.00
  •  533.00
  •  535.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  491046
  •  2717.82
  •  572.70
  •  130.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,760.58
  • 50.77
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,341.73
  • 0.36%
  • 7.24

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.77%
  • 3.62%
  • 19.69%
  • FII
  • DII
  • Others
  • 4.2%
  • 0.61%
  • 3.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.61
  • 10.24
  • 5.16

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.63
  • 8.60
  • 2.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.60
  • 15.43
  • 3.02

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.04
  • 25.67
  • 21.95

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.84
  • 3.04
  • 2.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.51
  • 10.50
  • 9.84

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
532.46
378.99
40.49%
463.29
404.06
14.66%
371.92
321.05
15.84%
352.77
403.16
-12.50%
Expenses
423.20
308.36
37.24%
371.97
328.41
13.26%
302.15
262.69
15.02%
300.29
334.65
-10.27%
EBITDA
109.26
70.63
54.69%
91.32
75.65
20.71%
69.77
58.36
19.55%
52.48
68.51
-23.40%
EBIDTM
20.52%
18.64%
19.71%
18.72%
18.76%
18.18%
14.88%
16.99%
Other Income
2.87
1.73
65.90%
0.52
0.47
10.64%
0.95
0.82
15.85%
0.64
0.68
-5.88%
Interest
9.97
13.70
-27.23%
8.05
13.09
-38.50%
8.50
13.58
-37.41%
9.62
12.05
-20.17%
Depreciation
21.55
20.94
2.91%
21.81
20.69
5.41%
21.17
20.51
3.22%
20.71
20.32
1.92%
PBT
80.61
37.72
113.71%
61.98
42.34
46.39%
41.05
9.69
323.63%
22.79
36.82
-38.10%
Tax
29.69
13.25
124.08%
21.70
13.98
55.22%
14.10
3.32
324.70%
7.79
11.59
-32.79%
PAT
50.92
24.47
108.09%
40.28
28.36
42.03%
26.95
6.37
323.08%
15.00
25.23
-40.55%
PATM
9.56%
6.46%
8.69%
7.02%
7.25%
1.98%
4.25%
6.26%
EPS
4.13
1.98
108.59%
3.27
2.30
42.17%
2.19
0.52
321.15%
1.22
2.05
-40.49%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,720.44
1,507.26
1,589.61
1,296.09
1,013.94
925.65
871.85
829.21
660.42
707.81
502.30
Net Sales Growth
14.14%
-5.18%
22.65%
27.83%
9.54%
6.17%
5.14%
25.56%
-6.70%
40.91%
 
Cost Of Goods Sold
908.38
776.32
853.82
698.90
508.88
464.89
427.14
376.04
261.31
312.98
212.77
Gross Profit
812.06
730.94
735.79
597.19
505.06
460.76
444.71
453.17
399.11
394.83
289.52
GP Margin
47.20%
48.49%
46.29%
46.08%
49.81%
49.78%
51.01%
54.65%
60.43%
55.78%
57.64%
Total Expenditure
1,397.61
1,234.11
1,291.48
1,054.35
815.48
744.81
689.44
642.09
476.25
524.57
382.97
Power & Fuel Cost
-
129.99
132.04
108.41
85.63
83.70
93.85
97.09
88.80
73.70
55.10
% Of Sales
-
8.62%
8.31%
8.36%
8.45%
9.04%
10.76%
11.71%
13.45%
10.41%
10.97%
Employee Cost
-
156.57
135.69
128.06
116.69
108.06
89.20
79.02
70.18
63.66
58.88
% Of Sales
-
10.39%
8.54%
9.88%
11.51%
11.67%
10.23%
9.53%
10.63%
8.99%
11.72%
Manufacturing Exp.
-
85.78
83.61
50.48
38.41
32.69
26.98
23.25
19.29
22.24
17.22
% Of Sales
-
5.69%
5.26%
3.89%
3.79%
3.53%
3.09%
2.80%
2.92%
3.14%
3.43%
General & Admin Exp.
-
43.05
35.77
28.33
30.77
26.86
24.93
23.24
19.86
19.43
15.88
% Of Sales
-
2.86%
2.25%
2.19%
3.03%
2.90%
2.86%
2.80%
3.01%
2.75%
3.16%
Selling & Distn. Exp.
-
20.45
23.36
22.52
18.02
17.09
18.92
16.02
10.97
16.24
13.82
% Of Sales
-
1.36%
1.47%
1.74%
1.78%
1.85%
2.17%
1.93%
1.66%
2.29%
2.75%
Miscellaneous Exp.
-
21.95
27.19
17.66
17.09
11.53
8.42
27.45
5.86
16.33
13.82
% Of Sales
-
1.46%
1.71%
1.36%
1.69%
1.25%
0.97%
3.31%
0.89%
2.31%
1.85%
EBITDA
322.83
273.15
298.13
241.74
198.46
180.84
182.41
187.12
184.17
183.24
119.33
EBITDA Margin
18.76%
18.12%
18.75%
18.65%
19.57%
19.54%
20.92%
22.57%
27.89%
25.89%
23.76%
Other Income
4.98
3.70
2.26
4.46
3.44
1.84
1.58
34.05
6.31
1.40
3.30
Interest
36.14
52.42
58.43
49.12
48.27
62.21
60.05
68.01
59.89
66.38
43.72
Depreciation
85.24
82.46
92.88
85.59
69.14
67.28
64.19
55.04
49.07
45.31
41.03
PBT
206.43
141.98
149.08
111.49
84.47
53.19
59.75
98.13
81.50
72.96
37.87
Tax
73.28
42.14
46.01
34.27
12.55
11.99
19.35
34.23
7.82
5.07
-2.31
Tax Rate
35.50%
33.29%
30.86%
30.74%
15.64%
22.54%
32.38%
34.88%
23.65%
9.92%
-6.65%
PAT
133.15
84.44
103.08
77.23
67.72
41.20
40.41
63.90
25.25
46.03
37.02
PAT before Minority Interest
133.15
84.44
103.08
77.23
67.72
41.20
40.41
63.90
25.25
46.03
37.02
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.74%
5.60%
6.48%
5.96%
6.68%
4.45%
4.63%
7.71%
3.82%
6.50%
7.37%
PAT Growth
57.70%
-18.08%
33.47%
14.04%
64.37%
1.95%
-36.76%
153.07%
-45.14%
24.34%
 
EPS
10.80
6.85
8.36
6.26
5.49
3.34
3.28
5.18
2.05
3.73
3.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
816.50
756.21
669.38
604.98
563.78
532.48
504.71
450.27
430.60
400.49
Share Capital
24.66
24.66
16.44
16.44
16.44
16.44
16.44
16.44
16.44
16.44
Total Reserves
791.84
731.55
652.95
588.54
547.34
516.04
488.27
433.83
414.16
384.05
Non-Current Liabilities
410.16
359.42
311.82
324.23
336.88
241.67
298.23
237.91
253.50
259.71
Secured Loans
303.40
297.84
296.63
320.15
296.61
201.44
254.56
213.43
240.18
256.58
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.27
6.20
5.50
0.70
Long Term Provisions
73.43
48.74
15.65
14.30
10.22
11.71
10.92
9.66
7.01
6.71
Current Liabilities
652.77
659.02
616.17
470.29
397.36
530.07
478.92
502.90
447.63
400.35
Trade Payables
201.16
160.01
164.55
130.43
127.87
137.21
131.19
112.94
114.47
83.12
Other Current Liabilities
133.28
136.11
113.94
75.93
62.03
131.52
100.19
123.63
114.56
112.65
Short Term Borrowings
257.54
301.88
277.16
230.24
171.96
231.01
215.55
260.28
205.47
191.34
Short Term Provisions
60.80
61.03
60.52
33.69
35.49
30.33
31.99
6.04
13.12
13.24
Total Liabilities
1,879.43
1,774.65
1,597.37
1,399.50
1,298.02
1,304.22
1,281.86
1,191.08
1,131.73
1,060.55
Net Block
735.22
712.96
633.59
668.33
623.18
639.35
643.85
660.48
639.30
635.29
Gross Block
1,064.92
960.28
788.33
737.47
1,147.23
1,096.12
1,031.78
992.97
922.32
872.28
Accumulated Depreciation
329.70
247.31
154.73
69.14
524.05
456.77
387.93
332.49
283.02
236.99
Non Current Assets
1,048.22
888.17
851.29
792.71
807.83
791.16
775.07
781.92
773.46
736.15
Capital Work in Progress
160.82
78.69
117.88
62.76
66.13
61.66
61.17
48.54
75.57
51.21
Non Current Investment
0.68
1.02
2.60
3.62
3.12
3.12
3.12
3.12
3.12
3.12
Long Term Loans & Adv.
145.30
85.40
91.55
37.81
85.55
72.03
66.93
69.78
55.47
46.53
Other Non Current Assets
6.21
10.11
5.67
20.20
29.86
15.00
0.00
0.00
0.00
0.00
Current Assets
831.22
886.48
746.08
606.79
490.19
513.06
506.79
409.17
358.26
324.40
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
312.46
364.23
303.05
263.58
291.11
313.95
311.29
257.03
192.77
172.28
Sundry Debtors
340.44
349.72
287.37
256.47
112.31
127.97
88.74
84.63
101.97
88.03
Cash & Bank
63.57
31.74
27.22
16.46
19.16
13.70
27.68
15.44
6.88
10.09
Other Current Assets
114.74
8.42
14.50
10.73
67.62
57.43
79.08
52.06
56.64
54.01
Short Term Loans & Adv.
104.25
132.37
113.93
59.54
57.43
35.02
45.72
27.60
36.05
36.34
Net Current Assets
178.44
227.45
129.91
136.51
92.84
-17.02
27.87
-93.73
-89.36
-75.95
Total Assets
1,879.44
1,774.65
1,597.37
1,399.50
1,298.02
1,304.22
1,281.86
1,191.09
1,131.72
1,060.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
284.93
185.59
138.81
163.48
185.61
102.18
154.41
61.05
136.52
108.01
PBT
141.98
149.08
111.49
80.27
53.19
59.75
98.13
33.07
51.11
34.71
Adjustment
136.17
158.81
140.35
126.88
133.68
126.82
112.36
105.39
95.41
73.19
Changes in Working Capital
46.49
-89.69
-87.16
-23.93
11.35
-71.33
-35.96
-72.02
-1.32
8.74
Cash after chg. in Working capital
324.64
218.21
164.69
183.22
198.22
115.24
174.53
66.44
145.20
116.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-24.31
-32.62
-25.87
-19.73
-12.61
-13.06
-20.11
-5.39
-8.68
-8.63
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-15.40
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-163.80
-124.59
-110.12
-102.17
-63.91
-42.89
-22.86
-28.02
-53.62
-74.64
Net Fixed Assets
-186.77
-132.76
-105.98
413.05
-55.58
-64.49
-51.45
-114.87
-69.56
-67.97
Net Investments
0.34
1.58
1.02
-0.50
0.00
0.00
0.00
15.04
0.00
0.00
Others
22.63
6.59
-5.16
-514.72
-8.33
21.60
28.59
71.81
15.94
-6.67
Cash from Financing Activity
-100.86
-55.40
-24.79
-63.28
-123.63
-68.82
-124.43
-27.01
-87.09
-38.05
Net Cash Inflow / Outflow
20.27
5.59
3.90
-1.96
-1.93
-9.53
7.12
6.02
-4.19
-4.68
Opening Cash & Equivalents
11.41
5.82
1.93
3.89
6.23
15.75
8.63
2.62
6.81
11.49
Closing Cash & Equivalent
31.68
11.41
5.82
1.93
4.29
6.23
15.75
8.63
2.62
6.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
66.22
61.33
54.29
49.07
37.16
34.56
32.25
27.77
26.11
23.61
ROA
4.62%
6.11%
5.15%
5.02%
3.17%
3.12%
5.17%
2.17%
4.20%
3.51%
ROE
10.74%
14.46%
12.12%
12.74%
9.32%
9.81%
17.27%
7.60%
15.02%
13.09%
ROCE
12.44%
15.25%
12.81%
11.87%
11.92%
12.50%
17.77%
10.44%
13.97%
9.80%
Fixed Asset Turnover
1.49
1.82
1.70
1.10
0.83
0.82
0.82
0.69
0.81
0.62
Receivable days
83.56
73.14
76.34
65.09
46.88
45.07
37.91
51.20
47.99
65.79
Inventory Days
81.93
76.61
79.54
97.91
118.04
130.03
124.28
123.43
92.21
124.67
Payable days
52.18
44.26
48.94
56.69
62.74
67.85
66.97
82.64
69.96
80.79
Cash Conversion Cycle
113.32
105.49
106.94
106.31
102.18
107.25
95.22
91.99
70.24
109.68
Total Debt/Equity
0.79
0.87
0.95
0.99
1.10
1.28
1.37
1.70
1.65
1.84
Interest Cover
3.41
3.55
3.27
2.66
1.85
2.00
2.44
1.55
1.77
1.79

News Update:


  • Hikal reports 2- fold jump in Q4 net profit
    6th May 2021, 16:59 PM

    Total income of the company increased by 40.61% at Rs 535.33 crore for Q4FY21

    Read More
  • Hikal signs 10-year multi product deal with leading global pharmaceutical innovator company
    5th May 2021, 09:45 AM

    With this deal, Hikal is entering into a niche area of chemistry and products thereby bolstering its Animal Health vertical

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.